Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparations used in clinical organ transplantation

Transplantation

Volumn 74, Issue 6, 2002, Pages 846-855

  Mathew, James M ^a   Carreno, Manuel ^a   Fuller, Laphalle ^a   Burke III, George W ^a   Ciancio, Gaetano ^a   Ricordi, Camillo ^a   Tzakis, Andreas G ^a   Esquenazi, Violet ^a   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RECOMBINANT INTERLEUKIN 2; TACROLIMUS;

ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CADAVER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; KIDNEY TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0037183857     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209270-00019     Document Type: Article

References (34)

1. Monaco AP, Clark AW, Wood ML, et al. Possible active enhancement of a human cadaver renal allograft with anti-lymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976; 79: 384.
2. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
3. McDaniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57: 852.
4. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344: 151.
5. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
6. Ricordi C, Karatzas T, Selvaggi G, et al. Multiple bone marrow infusions to enhance acceptance of allografts from the same donor. Ann N Y Acad Sci 1995; 770: 345.
7. Garcia-Morales R, Carreno M, Mathew JM, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest 1997; 99: 1118.
8. Garcia-Morales R, Carreno M. Mathew JM, et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 1998; 65: 956.
9. Ciancio G, Miller J, Garcia-Morales R, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001; 71: 827.
10. Miller J, Mathew JM, Garcia-Morales R, et al. The human bone marrow as an immunoregulatory organ. Transplantation 1999; 68: 1079.
11. Mathew JM, Carreno M, Fuller L, et al. Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 1997; 63: 686.
12. Mathew JM, Carreno M, Zucker K, et al. Cellular immune responses of human cadavers and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 1998; 65: 947.
13. Mathew JM, Carreno M, Fuller L, et al. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation. Transplantation 1999; 68: 1172.
14. Mathew JM, Fuller L, Carreno M, et al. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 2000; 70: 1752.
15. Ricordi C, Karatzas T, Nery J, et al. Effect of timing of donor bone marrow infusions on liver allograft survival. Transplant Proc 1997; 29: 1186.
16. Pinna AD, Weppler D, Berho M, et al. Unusual presentation of graft-versus-host disease in pediatric liver transplant recipients: evidence of late and recurrent disease. Pediatr Transplant 1999; 3: 236.
17. Mathew JM, Garcia-Morales R, Fuller L, et al. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation 2000; 70: 1675.
18. Mathew JM, Miller J. Immunoregulatory role of chimerism in clinical organ transplantation [editorial]. Bone Marrow Transplant 2001; 28: 115.
19. +) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood 2001; 98: 390.
20. Affaticati P, Locatelli F, Roggero S, et al. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 2000; 26: 517.
21. Mutis T, Gillespie G, Schrama E, et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen -specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839.
22. Morohashi T, Ogasawara K, Kitaichi N, et al. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD. Bone Marrow Transplant 2000; 26: 1069.
23. Ciubotariu R, Vasilescu R, Ho E, et al. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 2001; 62: 15.
24. Lan F, Hayamizu K, Strober S. Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after post-transplant total lymphoid irradiation. Transplantation 2000; 69: 649-655.
25. Beverly B, Kang S-M, Lenardo MJ, et al. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 1992; 4: 661.
26. Miller RG. An immunological suppressor cell which inactivates cytotoxic T lymphocyte precursor cells recognizing it. Nature 1980; 287: 544.
27. Thomas JM, Verbanac KM, Thomas FT. The veto mechanism in transplant tolerance. Transplant Rev 1991; 5: 209
28. Strober S, Okada S, OseroffA. Role of natural suppressor cells in allograft tolerance. Fed Proc 1984; 43: 263.
29. Schmidt-Wolf IG, Dejbakhsh-Jones S, Ginzton N, et al. T-cell subsets and suppressor cells in human bone marrow. Blood 1992; 80: 3242.
30. Sugiura K, Pahwa S, Yamamoto Y, et al. Characterization of natural suppressor cells in human bone marrow. Stem Cells 1998; 16: 99.
31. Steinmuller D, Hart EA. Passenger leukocytes and induction of allograft immunity. Transplant Proc 1971; 3: 673.
32. Sykes M, Chester CH, Sachs DH. Protection from graft-versus-host disease in fully allogeneic chimeras by prior administration of T cell-depleted syngeneic bone marrow. Transplantation 1988; 46: 327.
33. Ildstad ST, Wren SM, Bluestone JA, et al. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2-B10). J Immunol 1986; 136: 28.
34. Ko S, Dahlke MH, Lauth O, et al. Bone marrow aplasia induced by passenger leukocytes from heart allografts. Exp Hematol 2001; 29: 339.